Impact of Abnormal Embryonic Molecular Karyotype Determined by Single Nucleotide Polymorphism (SNP) Microarray Preimplantation Genetic Diagnosis (PGD) on Embryo Development and Blastocyst Formation

G. Li,H. Jin,Z. Xin,Y. Guo,Y. Su,Y. Sun
DOI: https://doi.org/10.1016/j.fertnstert.2012.07.599
IF: 6.7
2012-01-01
Fertility and Sterility
Abstract:ObjectiveTo determine the influence of 23-chromosome embryonic molecular karyotype on embryo development capacity and blastocyst formation.DesignRetrospective.Materials and MethodsIRB approval was obtained. Patients underwent in vitro fertilization (IVF) and PGD/PGS. Single blastomeres from Day-3 embryos underwent DNA amplification and 23-chromosome SNP microarray analysis using HumanCytoSNP-12 DNA beadchips and GenomeStudio software. These biopsied embryos were continuously cultured to day 5 and embryo development and blastocyst formation were observed.Results84 patients were enrolled.722 embryos were subjected to D-3 biopsy. 630 embryos had 23-chromosome molecular karyotyping as well as culture outcomes on D-5. Blastocyst formation rate of normal 23-chromosome molecular karyotype embryos was 58.3%(201/345), which was significantly higher than that of abnormal embryos 22.8%(65/285)(P=0.00). Blastocyst formation rates were not significantly different among embryos grouped by maternal age<30(41.7%),30-35 (42%) and>35 years old(44.2%). The blastocyst formation of male and female embryos was 45.3% and 38.1% respectively, no significant difference observed (P=0.199). Blastocyst formation rate of embryos with different abnormal molecular karyotypes had no significant difference (P=0.95).ConclusionNormal 23-chromosome molecular karyotype embryos have significant higher developmental potential and blastocyst formation rate than abnormal embryos. However, maternal age, sex of embryo and different abnormal molecular karyorypes have no significant impact on preimplatation embryo development. To our knowledge, this is the first and the largest comprehensive trial conducted evaluating the influence of 23-chromosome molecular karyotype on embryonic development. ObjectiveTo determine the influence of 23-chromosome embryonic molecular karyotype on embryo development capacity and blastocyst formation. To determine the influence of 23-chromosome embryonic molecular karyotype on embryo development capacity and blastocyst formation. DesignRetrospective. Retrospective. Materials and MethodsIRB approval was obtained. Patients underwent in vitro fertilization (IVF) and PGD/PGS. Single blastomeres from Day-3 embryos underwent DNA amplification and 23-chromosome SNP microarray analysis using HumanCytoSNP-12 DNA beadchips and GenomeStudio software. These biopsied embryos were continuously cultured to day 5 and embryo development and blastocyst formation were observed. IRB approval was obtained. Patients underwent in vitro fertilization (IVF) and PGD/PGS. Single blastomeres from Day-3 embryos underwent DNA amplification and 23-chromosome SNP microarray analysis using HumanCytoSNP-12 DNA beadchips and GenomeStudio software. These biopsied embryos were continuously cultured to day 5 and embryo development and blastocyst formation were observed. Results84 patients were enrolled.722 embryos were subjected to D-3 biopsy. 630 embryos had 23-chromosome molecular karyotyping as well as culture outcomes on D-5. Blastocyst formation rate of normal 23-chromosome molecular karyotype embryos was 58.3%(201/345), which was significantly higher than that of abnormal embryos 22.8%(65/285)(P=0.00). Blastocyst formation rates were not significantly different among embryos grouped by maternal age<30(41.7%),30-35 (42%) and>35 years old(44.2%). The blastocyst formation of male and female embryos was 45.3% and 38.1% respectively, no significant difference observed (P=0.199). Blastocyst formation rate of embryos with different abnormal molecular karyotypes had no significant difference (P=0.95). 84 patients were enrolled.722 embryos were subjected to D-3 biopsy. 630 embryos had 23-chromosome molecular karyotyping as well as culture outcomes on D-5. Blastocyst formation rate of normal 23-chromosome molecular karyotype embryos was 58.3%(201/345), which was significantly higher than that of abnormal embryos 22.8%(65/285)(P=0.00). Blastocyst formation rates were not significantly different among embryos grouped by maternal age<30(41.7%),30-35 (42%) and>35 years old(44.2%). The blastocyst formation of male and female embryos was 45.3% and 38.1% respectively, no significant difference observed (P=0.199). Blastocyst formation rate of embryos with different abnormal molecular karyotypes had no significant difference (P=0.95). ConclusionNormal 23-chromosome molecular karyotype embryos have significant higher developmental potential and blastocyst formation rate than abnormal embryos. However, maternal age, sex of embryo and different abnormal molecular karyorypes have no significant impact on preimplatation embryo development. To our knowledge, this is the first and the largest comprehensive trial conducted evaluating the influence of 23-chromosome molecular karyotype on embryonic development. Normal 23-chromosome molecular karyotype embryos have significant higher developmental potential and blastocyst formation rate than abnormal embryos. However, maternal age, sex of embryo and different abnormal molecular karyorypes have no significant impact on preimplatation embryo development. To our knowledge, this is the first and the largest comprehensive trial conducted evaluating the influence of 23-chromosome molecular karyotype on embryonic development.
What problem does this paper attempt to address?